Skip to content

Advertisement

Volume 6 Supplement 6

Beyond the Genome 2012

  • Oral presentation
  • Open Access

Analyzing genomes: is there a duty to disclose?

  • 1
BMC Proceedings20126 (Suppl 6) :O14

https://doi.org/10.1186/1753-6561-6-S6-O14

  • Published:

Keywords

  • Public Health
  • Genetic Variant
  • Clinical Setting
  • Association Study
  • Genomic Analysis

The potential to discover unanticipated clinically significant genetic variants during the course of research has stimulated much debate about the obligations of researchers to communicate such findings to study participants. Published guidelines suggest that researchers have an obligation to communicate valid and significant results, especially if they are clinically actionable. I will present data on the practices and perspectives of investigators conducting genome-wide association studies (GWAS) and will caution against the establishment of a general obligation to return results in research. I will compare the role-specific responsibilities of researchers with those of clinicians and discuss emerging standards for genomic analysis and communication of test results in the clinical setting.

Authors’ Affiliations

(1)
Baylor College of Medicine, Houston, TX, USA

Copyright

Advertisement